UPDATED Aug 12, 2022
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
4507Shionogi | JPÂ¥6,916.00 | 2.4% | 5.8% | JPÂ¥2.1t | JPÂ¥8,010.83 | PE17.8x | E1.7% | 1.7% | ||
600196Shanghai Fosun Pharmaceutical (Group) | CNÂ¥43.91 | 1.3% | -38.8% | CNÂ¥106.2b | CNÂ¥46.82 | PE26.9x | E19.1% | 1.3% | ||
BIOBio-Rad Laboratories | US$548.74 | 1.7% | -29.5% | US$16.1b | US$641.33 | PS5.7x | E142.1% | n/a | ||
INCYIncyte | US$73.99 | 2.5% | 0.7% | US$16.5b | US$88.71 | PE17.4x | E30.0% | n/a | ||
BMRNBioMarin Pharmaceutical | US$95.07 | -0.8% | 26.7% | US$17.6b | US$114.14 | PE325.3x | E48.3% | n/a | ||
603392Beijing Wantai Biological Pharmacy Enterprise | CNÂ¥138.13 | 0.6% | -19.0% | CNÂ¥121.6b | CNÂ¥204.78 | PE39.7x | E26.7% | 0.1% | ||
300896Imeik Technology DevelopmentLtd | CNÂ¥567.20 | -3.2% | -8.1% | CNÂ¥122.7b | CNÂ¥668.12 | PE115x | E38.4% | 0.4% | ||
4578Otsuka Holdings | JPÂ¥4,688.00 | 0.6% | 0.04% | JPÂ¥2.5t | JPÂ¥4,809.09 | PE24.5x | E3.9% | 2.1% | ||
AVTRAvantor | US$28.56 | 0.03% | -26.0% | US$19.3b | US$38.07 | PE33.6x | E21.7% | n/a | ||
ICLRICON | US$241.24 | 3.5% | 0.9% | US$19.7b | US$269.67 | PE93.7x | E29.4% | n/a | ||
CTLTCatalent | US$109.97 | -0.5% | -8.8% | US$19.7b | US$135.17 | PE40.6x | E16.2% | n/a | ||
PKIPerkinElmer | US$157.91 | 2.7% | -13.8% | US$19.9b | US$173.40 | PE29.6x | E3.9% | 0.2% | ||
BGNEBeiGene | US$193.97 | -0.3% | -29.8% | US$20.1b | US$275.30 | PS18.8x | E46.1% | n/a | ||
WATWaters | US$335.23 | -0.8% | -17.3% | US$20.1b | US$346.64 | PE28.6x | E6.3% | n/a | ||
ARGXargenx | €366.10 | 1.6% | 37.3% | €20.2b | €409.72 | PS141.3x | E74.3% | n/a | ||
A068270Celltrion | â‚©208,000.00 | 5.6% | -23.0% | â‚©28.7t | â‚©215,100.00 | PE57x | E22.4% | 0.4% | ||
300122Chongqing Zhifei Biological Products | CNÂ¥98.40 | -1.3% | -37.6% | CNÂ¥157.4b | CNÂ¥143.59 | PE14.1x | E11.9% | 0.6% | ||
GMABGenmab | kr.2,636.00 | 3.1% | -10.6% | kr.172.1b | kr.2,671.50 | PE43.4x | E24.2% | n/a | ||
WSTWest Pharmaceutical Services | US$340.98 | -0.2% | -21.5% | US$25.2b | US$371.29 | PE36.8x | E9.0% | 0.2% | ||
RPRXRoyalty Pharma | US$44.20 | 4.1% | 14.1% | US$26.8b | US$53.95 | PE41.5x | E54.5% | 1.7% | ||
600436Zhangzhou Pientzehuang Pharmaceutical | CNÂ¥300.01 | 0.4% | -22.5% | CNÂ¥181.0b | CNÂ¥354.56 | PE70.8x | E22.0% | 0.4% | ||
SUNPHARMASun Pharmaceutical Industries | ₹913.45 | -0.3% | 17.4% | ₹2.2t | ₹1,060.37 | PE56.3x | E16.0% | 1.1% | ||
4503Astellas Pharma | JPÂ¥2,034.50 | 0.7% | 13.8% | JPÂ¥3.7t | JPÂ¥2,600.00 | PE31.4x | E17.2% | 2.9% | ||
ALNYAlnylam Pharmaceuticals | US$233.85 | 7.0% | 19.0% | US$28.1b | US$227.35 | PS31.7x | E69.3% | n/a |